GHO Capital and CBC Group agreed to combine their healthcare investment platforms to create what the firms said will be the world’s largest dedicated healthcare investment firm. The combined organization is expected to manage approximately $15 billion in assets focused exclusively on healthcare investments across Europe, North America and Asia. Financial terms of the transaction were not disclosed.
London-based GHO Capital is a healthcare-focused private equity firm investing across pharma services, medtech, healthcare services and specialty pharmaceuticals, while Singapore-headquartered CBC Group is an investment platform focused on healthcare, biotech and life sciences. The firms said the combination is intended to expand global investment capabilities across biopharma, medical technology, diagnostics and healthcare delivery while increasing access to cross-border healthcare transactions and growth opportunities.
Both firms have been extremely active in the healthcare M&A market, especially GHO Capital, which has announced 30 deals since 2015. In 2024, it announced its largest deal, partnering with Ampersand Capital Partners to buy Avid Bioservices in a $1.1 billion all-cash transaction.
CBC has announced several deals since 2015. In 2024, the company announced a $680 million acquisition of UCB‘s mature business in China (neurology and allergy), in partnership with Mubadala Investment Company.
The combined platform will operate across multiple healthcare subsectors and geographies with investment teams spanning Europe, the United States and Asia-Pacific markets. The firms said existing portfolio companies and investment strategies will continue under the combined organization, which is expected to pursue additional healthcare buyouts, growth investments and strategic partnerships globally.
